Optel Group expands pharma traceability offering with acquisition
The global provider of track and trace systems has announced its acquisition of Verify Brand.
The move will empower Optel to provide end-to-end solutions for pharmaceutical and medical device firms, as well as the ability to cater for other supply chain industries.
The addition of Verify Brand’s Level 4/5 serialization capabilities and established data analytics expertise allows Optel Group to provide the connectivity pharma companies desire for complete track and trace projects.
Visions for the company entail the deployment of artificial intelligence to examine big data from supply chains to gain actionable insights to better processes and practices.
“Our plan is to optimize supply chains to increase our customers’ performance while at the same time building a sustainable economy in the long term,” states Louis Roy, President of Optel Group.
Verify Brand CEO, Michael Howe said: “Combining our mature, flexible serialization platform with Optel’s Track & Trace capabilities will open up access to the data, analytics and reports that brands need to finally enable this level of visibility.
“We believe that the innovations we can deliver, in combination with the Optel team, will create solutions that meet the demands of brands both today, and into the future.”